Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica M Clement

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Oncology Practice|January 4, 2017
Evolving Treatment of Oligometastatic Hormone-Sensitive Prostate CancerJessica M Clement, Christopher J Sweeney
Clinical Genitourinary Cancer|August 21, 2009
The high-dose aldesleukin (IL-2) "select" trial: a trial designed to prospectively validate predictive models of response to high-dose IL-2 treatment in patients with metastatic renal cell carcinomaJessica M Clement, David F McDermott
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 23, 2015
Physician-pharmacist collaboration for oral chemotherapy monitoring: Insights from an academic genitourinary oncology practiceLisa M Holle, Sonam Puri, Jessica M Clement
Oncoimmunology|September 26, 2015
Smoking-induced immune deviation contributes to progression of bladder and other cancersJessica M Clement, Fei Duan, Pramod K Srivastava
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 11, 2018
Potential role of rituximab in metastatic castrate-resistant prostate cancerPoorva Bindal, Sharif Aa Jalil, Lisa M Holle, et al.
Case Reports in Urology|March 16, 2016
Hematospermia and Cloacogenic Transitional Cell Carcinoma: A Twist on Significance and MeaningAlex M Hennessey, Jessica M Clement, Faripour Forouhar, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 29, 2017
Subcutaneous metastasis from recurrent basaloid squamous cell carcinoma of the esophagusSonam Puri, Lisa M Holle, Faripour A Forouhar, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|November 2, 2014
Atypical presentation of fever as hypersensitivity reaction to oxaliplatinArushi Khurana, Demytra Mitsis, Gurukripa N Kowlgi, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 24, 2015
Impact of a pharmacist-led oral chemotherapy-monitoring program in patients with metastatic castrate-resistant prostate cancerJay M Patel, Lisa M Holle, Jessica M Clement, et al.
Urologic Oncology|October 29, 2017
SATB1 and bladder cancer: Is there a functional link?Dharamainder Choudhary, Jessica M Clement, Shilpa Choudhary, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Oncology Practice|January 4, 2017
Evolving Treatment of Oligometastatic Hormone-Sensitive Prostate CancerJessica M Clement, Christopher J Sweeney
Clinical Genitourinary Cancer|August 21, 2009
The high-dose aldesleukin (IL-2) "select" trial: a trial designed to prospectively validate predictive models of response to high-dose IL-2 treatment in patients with metastatic renal cell carcinomaJessica M Clement, David F McDermott
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 23, 2015
Physician-pharmacist collaboration for oral chemotherapy monitoring: Insights from an academic genitourinary oncology practiceLisa M Holle, Sonam Puri, Jessica M Clement
Oncoimmunology|September 26, 2015
Smoking-induced immune deviation contributes to progression of bladder and other cancersJessica M Clement, Fei Duan, Pramod K Srivastava
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 11, 2018
Potential role of rituximab in metastatic castrate-resistant prostate cancerPoorva Bindal, Sharif Aa Jalil, Lisa M Holle, et al.
Case Reports in Urology|March 16, 2016
Hematospermia and Cloacogenic Transitional Cell Carcinoma: A Twist on Significance and MeaningAlex M Hennessey, Jessica M Clement, Faripour Forouhar, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 29, 2017
Subcutaneous metastasis from recurrent basaloid squamous cell carcinoma of the esophagusSonam Puri, Lisa M Holle, Faripour A Forouhar, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|November 2, 2014
Atypical presentation of fever as hypersensitivity reaction to oxaliplatinArushi Khurana, Demytra Mitsis, Gurukripa N Kowlgi, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 24, 2015
Impact of a pharmacist-led oral chemotherapy-monitoring program in patients with metastatic castrate-resistant prostate cancerJay M Patel, Lisa M Holle, Jessica M Clement, et al.
Urologic Oncology|October 29, 2017
SATB1 and bladder cancer: Is there a functional link?Dharamainder Choudhary, Jessica M Clement, Shilpa Choudhary, et al.
Pageof 1